Skip navigation

State-by-State Requirements and Reporting • Current and Future Policy Initiatives • Operational Best Practices

March 25-26, 2019
  • Philadelphia, PA

New for 2019! Join us for a pre-conference workshop: Medicare and Reimbursement —
A Deep Dive Into the International Pricing Model
March 25, 2019  |  12:30–5:00pm

As state and federal legislatures across the nation continue to pass laws aimed at transparency and reporting obligations, drug pricing regulations remain a highlight in the headlines. This leaves numerous unanswered questions and a myriad of legislative and compliance complexities that are going to affect the market in real time. Are you prepared for the impact on drug pricing and compliance practices?

Join CBI’s 4th Edition Drug Pricing Transparency Congress, a  program that convenes stakeholders to discuss how the future of drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices. Learn what is driving the new laws of 2019 and proposed objectives of the legislation to grasp best practices and implement strategic steps.

Featured Sessions Include:

  • Review drug pricing transparency legislative and litigation
    developments — including a deep dive state-by-state analysis
    of laws in Oregon, California, Nevada, Connecticut, New York
    and Vermont
  • Explore how the future of drug pricing transparency regulation
    will impact commercialization, reimbursement and
    drug pricing models
  • Deliver comprehensive legal interpretations of drug pricing
    transparency and reporting laws currently on the books and
    the policy outlook for 2019
  • Benchmark overall state compliance practices related to
    drug pricing reporting
  • Discuss organizational shifts within legal and compliance
    departments to handle drug pricing obligations and reporting

Don’t miss this timely event — register today!

4th Edition Drug Pricing Transparency Congress

State-by-State Requirements and Reporting • Current and Future Policy Initiatives • Operational Best Practices

New for 2019! Join us for a pre-conference workshop: Medicare and Reimbursement —
A Deep Dive Into the International Pricing Model
March 25, 2019  |  12:30–5:00pm

As state and federal legislatures across the nation continue to pass laws aimed at transparency and reporting obligations, drug pricing regulations remain a highlight in the headlines. This leaves numerous unanswered questions and a myriad of legislative and compliance complexities that are going to affect the market in real time. Are you prepared for the impact on drug pricing and compliance practices?

Join CBI’s 4th Edition Drug Pricing Transparency Congress, a  program that convenes stakeholders to discuss how the future of drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices. Learn what is driving the new laws of 2019 and proposed objectives of the legislation to grasp best practices and implement strategic steps.

Featured Sessions Include:

  • Review drug pricing transparency legislative and litigation
    developments — including a deep dive state-by-state analysis
    of laws in Oregon, California, Nevada, Connecticut, New York
    and Vermont
  • Explore how the future of drug pricing transparency regulation
    will impact commercialization, reimbursement and
    drug pricing models
  • Deliver comprehensive legal interpretations of drug pricing
    transparency and reporting laws currently on the books and
    the policy outlook for 2019
  • Benchmark overall state compliance practices related to
    drug pricing reporting
  • Discuss organizational shifts within legal and compliance
    departments to handle drug pricing obligations and reporting

Don’t miss this timely event — register today!